Publications from the Gaw Lab

See our full list of publications on PUBMED 

Work from the past year:

  1. Stressful life events and hypertensive disorders of pregnancy: The role of maternal and fetal inflammation.
    Eick SM, Ortlund K, Dunlop AL, Li L, Morello-Frosch R, Woodruff TJ, Gaw SL, Brennan PA, Liang D, Barr DB, Robinson JF, Goin DE.  Pregnancy Hypertens. 2026 Mar 12;44:101440. doi: 10.1016/j.preghy.2026.101440. Epub ahead of print. PMID: 41825090.
  2. Regional variation in maternal RSV vaccine access and attitudes across two California cohorts.
    Cirillo AA, Zeme M, Morales A, Rahseparian N, Cortez C, Gaw SL, Blauvelt CA.  Prev Med Rep. 2026 Feb 11;63:103408. doi: 10.1016/j.pmedr.2026.103408. PMID: 41756026; PMCID: PMC12933853.
  3. Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in Uganda
    Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME. Int J Epidemiol. 2026 Jan 2;55(1):dyag005. doi: 10.1093/ije/dyag005. PMID: 41657027.
  4. Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm Birth.
    Rackaityte E, Borges B, Kortbawi HM, Miller HS, Shao SJ, Zorn KC, Caspar C, Wong R, McCarthy F, Creery JS, Mayer M, Kouame E, Puccinelli RR, Kistler AL, Yu DJL, Ganem SR, DeRisi A, Kawaja Q, Wang CY, Saxena A, Oltman S, Kung AF, Mann SA, Mitchell A, Huang D, Rizzuto G, Baer RJ, Mandel-Brehm C, Ryckman KK, Gaw SL, Hillman SL, Jelliffe-Pawlowski LL, Halkias J, Sobhani NC, Anderson MS, Trespidi F, Alpin C, Bosoni T, Albertini R, Bellingeri C, Gardella B, Borghesi A, Prince N, Lasky-Su J, Wilson MR, Cedars M, Elias JE, MacKenzie TC, DeRisi JL.  medRxiv [Preprint]. 2025 Dec 5:2024.10.03.24314850. doi: 10.1101/2024.10.03.24314850. PMID: 41568202; PMCID: PMC12817887.
  5. Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from Uganda.
    Aguti M, Kizza J, Kakuru A, Nakalembe M, Nankabirwa JI, Gaw SL, Opira B, Ssemukuye T, Ozarslan N, Ranjit A, Dela Cruz E, Clark TD, Roh ME, Jagannathan P, Rosenthal PJ, Adrama H, Olwoch P, Mayende J, Odongo B, John A, Kamya M, Dorsey G.  Malar J. 2025 Dec 30;25(1):30. doi: 10.1186/s12936-025-05746-3. PMID: 41469677; PMCID: PMC12797446.
  6. Serum soluble fms-like tyrosine kinase kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy.
    Berg AH, Calsavara VF, Hund M, Guo G, Rana S, Costantine MM, Espinoza J, Boggess K, Wylie BJ, Moore Simas TA, Louis JM, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Bautista M, Lemoine E, Kilpatrick S, Thadhani R, Karumanchi SA.  Am J Obstet Gynecol. 2025 Nov 11:S0002-9378(25)00828-2. doi: 10.1016/j.ajog.2025.11.006. Epub ahead of print. PMID: 41232788.
  7. Dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda.
    Kakuru A, Kizza J, Aguti M, Adrama H, Ategeka J, Olwoch P, Nakalembe M, Nankabirwa JI, Opira B, Ozarslan N, Ranjit A, Dela Cruz E, Clark TD, Roh ME, Gaw SL, Jagannathan P, Rosenthal PJ, Kamya MR, Dorsey G. PLoS Med. 2025 Sep 18;22(9):e1004582. doi: 10.1371/journal.pmed.1004582. PMID: 40966190; PMCID: PMC12445490.
  8. Genomic characterization of normal and aberrant human milk production. 
    Golan Y, Nyquist SK, Liu Z, Ennis D, Zhao J, Blair E, Khan AR, Prahl M, Gaw SL, Yassour M, Engelhardt BE, Flaherman VJ, Ahituv N.  Sci Adv. 2025 Sep 12;11(37):eadr7174. doi: 10.1126/sciadv.adr7174. Epub 2025 Sep 10. PMID: 40929253; PMCID: PMC12422191.
  9. Associations between brominated and organophosphate flame retardant levels and inflammatory biomarkers in maternal blood, cord blood, and placental tissue at mid-gestation. 
    Nguyen V, Sehgal N, Li L, Goin DE, Morello-Frosch R, Woodruff TJ, Varshavsky J, Park JS, Gaw SL, Robinson JF, Eick SM.  Sci Total Environ. 2025 Sep 16;1001:180501. doi: 10.1016/j.scitotenv.2025.180501. Epub ahead of print. PMID: 40961615; PMCID: PMC12462692.
  10. An ex vivo human placental explant model for controlled exposure studies. 
    Ozarslan N, Li L, Buarpung S, Robinson JF, Gaw SL. STAR Protoc. 2025 Sep 19;6(3):104055. doi: 10.1016/j.xpro.2025.104055. Epub 2025 Aug 29. PMID: 40886312; PMCID: PMC12418815.
  11. Regulatory KIR+CD8+ T cells are elevated during human pregnancy.
    Li J, Wang X, Lackner AI, Narasimhan P, Li L, Mallajosyula V, Johnson MM, Höbler AL, Kirosingh AS, Braun AE, Nankya F, Musinguzi K, Kakuru A, Kamya M, Rosenthal PJ, Dorsey G, Jagannathan P, Angelo M, Pollheimer J, Gaw SL, Winn VD, Nadeau KC, Davis MM.  Sci Transl Med. 2025 Aug 6;17(810):eadm7697. doi: 10.1126/scitranslmed.adm7697. Epub 2025 Aug 6. PMID: 40768597.
  12. Maternal fever during labor and the risk of neonatal encephalopathy: duration and magnitude of hyperthermia. 
    Cornet MC, Kuzniewicz MW, Scheffler AW, Garabedian C, Gaw SL, Wu YW. Am J Obstet Gynecol. 2025 Dec;233(6):651.e1-651.e12. doi: 10.1016/j.ajog.2025.07.046. Epub 2025 Aug 5. PMID: 40754173; PMCID: PMC12412422.
  13. Pregnancy and lactation induce distinct immune responses to COVID-19 booster vaccination and SARS-CoV-2 breakthrough infection.
    Yin K†, Li L†, Luo X, Neidleman J, Cassidy AG, Golan Y, Ozarslan N, Lin CY, Jigmeddagva U, Ilala M, Chidboy MA, Prahl M*, Gaw SL*, Roan NR*. JCI Insight. 2025 Jul 22;10(14):e191930. doi: 10.1172/jci.insight.191930. PMID: 40693463. †Co-first authors. *Co-corresponding authors.
  14. Respiratory Syncytial Virus Vaccination Acceptance: The Importance of Asking "Why?".
    Zeme M, Gaw SL. J Pediatr Clin Pract. 2025 Jul 7;17:200163. doi: 10.1016/j.jpedcp.2025.200163. PMID: 40703621; PMCID: PMC12284778.
  15. Profiling the Cytotoxic Effects of Naled and Other Pesticides in Primary Human Placental Cytotrophoblast.
    Li L†, Chen H†, Jigmeddagva U, Le N, Kapidzic M, Gee S, Ali A, Levan J, Person R, Chen J, Gutierrez A, Okorie CN, Wang M, Woodruff TJ, Fisher SJ, Gaw SL, Robinson JF. Toxicol Sci. 2025 May 28:kfaf038. doi: 10.1093/toxsci/kfaf038. Epub ahead of print. PMID: 40434365. †Co-first authors
  16. Psychosocial stress and associations with inflammation in mid-gestation maternal, fetal, and placental tissue.
    Sehgal N, Li L, Goin DE, Chen J, Jigmeddagva U, Morello-Frosch R, Woodruff TJ, Gaw SL, Robinson JF, Eick SM. Reprod Toxicol. 2025 Apr 18;135:108922. doi: 10.1016/j.reprotox.2025.108922. Epub ahead of print. PMID: 40254104.
  17. Disparities in COVID-19 Vaccine Uptake Among Pregnant People in a Diverse Urban Population With High Vaccine Acceptance. 
    Blauvelt CA, Pullins MJ, Gaw SL. AJPM Focus. 2025 Jun;4(3):100303. doi: 10.1016/j.focus.2024.100303. eCollection 2025 Jun. PMID: 39967683;  PMCID: PMC11834080.
  18. Placental malaria induces a unique methylation profile associated with fetal growth restriction. 
    Ozarslan N, Mong C, Ategeka J, Li L, Buarpung S, Robinson JF, Kizza J, Kakuru A, Kamya MR, Dorsey G, Rosenthal PJ, Gaw SL. Epigenetics. 2025 Dec;20(1):2475276. doi: 10.1080/15592294.2025.2475276. Epub 2025 Mar 6. PMID: 40051167; PMCID: PMC11901535.
  19. Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates. 
    Blauvelt CA, Zeme M, Natarajan A, Epstein A, Roh ME, Morales A, Bourdoud N, Flaherman VJ, Prahl MK, Gaw SL. JAMA Netw Open. 2025 Feb 3;8(2):e2460735. doi: 10.1001/jamanetworkopen.2024.60735. PMID: 39969879; PMCID: PMC11840647.

Publications by Research Area

Malaria in Pregnancy- Translational
  1. Placental malaria induces a unique methylation profile associated with fetal growth restriction. 
    Ozarslan N, Mong C, Ategeka J, Li L, Buarpung S, Robinson JF, Kizza J, Kakuru A, Kamya MR, Dorsey G, Rosenthal PJ, Gaw SL. Epigenetics. 2025 Dec;20(1):2475276. doi: 10.1080/15592294.2025.2475276. Epub 2025 Mar 6. PMID: 40051167; PMCID: PMC11901535.
  2. Dysregulation of placental vascular development- a mechanism for adverse pregnancy outcomes in placental malaria.
    Ozarslan N, Gaw SL. EBioMedicine. 2021 Dec;74:103726. doi: 10.1016/j.ebiom.2021.103726. Epub 2021 Nov 26. PMID: 34844194; PMCID: PMC8633864.
  3. Gravidity-dependent associations between interferon response and birth weight in placental malaria. 
    Quanquin NM, Barres LG, Aliyari SR, Day NT, Gerami H, Fisher SJ, Kakuru A, Kamya MR, Havlir DV, Feeney M, Dorsey G, Cheng G, Gaw SL. Malar J. 2020 Aug 5;19(1):280. doi: 10.1186/s12936-020-03351-0. PMID: 32758231; PMCID: PMC7409479.
  4. Circulating Monocytes, Tissue Macrophages, and Malaria. 
    Ozarslan N, Robinson JF, Gaw SL. J Trop Med. 2019;2019:3720838. doi: 10.1155/2019/3720838. eCollection 2019. Review. PMID: 31662766; PMCID: PMC6791199.
  5. Differential Activation of Fetal Hofbauer Cells in Primigravidas Is Associated with Decreased Birth Weight in Symptomatic Placental Malaria. 
    Gaw SL, Hromatka BS, Ngeleza S, Buarpung S, Ozarslan N, Tshefu A, Fisher SJ. Malar Res Treat. 2019;2019:1378174. doi: 10.1155/2019/1378174. eCollection 2019. PMID: 31186834; PMCID: PMC6521392.
  6. Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes. 
    Kapisi J, Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Ssekitoleko R, Olwoch P, Ategeka J, Nayebare P, Clark TD, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G, Gaw SL. Malar J. 2017 Oct 5;16(1):400. PMID: 28982374; PMCID: PMC5629777.
Malaria in Pregnancy- Clinical Epidemiology
  1. Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in Uganda
    Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME. Int J Epidemiol. 2026 Jan 2;55(1):dyag005. doi: 10.1093/ije/dyag005. PMID: 41657027.
  2. Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from Uganda.
    Aguti M, Kizza J, Kakuru A, Nakalembe M, Nankabirwa JI, Gaw SL, Opira B, Ssemukuye T, Ozarslan N, Ranjit A, Dela Cruz E, Clark TD, Roh ME, Jagannathan P, Rosenthal PJ, Adrama H, Olwoch P, Mayende J, Odongo B, John A, Kamya M, Dorsey G.  Malar J. 2025 Dec 30;25(1):30. doi: 10.1186/s12936-025-05746-3. PMID: 41469677; PMCID: PMC12797446.
  3. Dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda.
    Kakuru A, Kizza J, Aguti M, Adrama H, Ategeka J, Olwoch P, Nakalembe M, Nankabirwa JI, Opira B, Ozarslan N, Ranjit A, Dela Cruz E, Clark TD, Roh ME, Gaw SL, Jagannathan P, Rosenthal PJ, Kamya MR, Dorsey G. PLoS Med. 2025 Sep 18;22(9):e1004582. doi: 10.1371/journal.pmed.1004582. PMID: 40966190; PMCID: PMC12445490.
  4. Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomised trial in Uganda.
    Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME. medRxiv [Preprint]. 2025 Jul 3:2025.07.02.25330769. doi: 10.1101/2025.07.02.25330769. PMID: 40630588; PMCID: PMC12236864.
  5. Generation of a malaria negative Ugandan birth weight standard for the diagnosis of small for gestational age. 
    Zakama AK, Weekes T, Kajubi R, Kakuru A, Ategeka J, Kamya M, Muhindo MK, Havlir D, Jagannathan P, Dorsey G, Gaw SL. PLoS One. 2020;15(10):e0240157. doi: 10.1371/journal.pone.0240157. eCollection 2020. PMID: 33007041; PMCID: PMC7531849.
  6. Placental Malaria. 
    Zakama AK, Ozarslan N, Gaw SL. Curr Trop Med Rep. 2020;7(4):162-171. doi: 10.1007/s40475-020-00213-2. Epub 2020 Sep 16. Review. PMID: 32953387; PMCID: PMC7493061.
  7. The impact of gravidity, symptomatology and timing of infection on placental malaria. 
    Tran EE, Cheeks ML, Kakuru A, Muhindo MK, Natureeba P, Nakalembe M, Ategeka J, Nayebare P, Kamya M, Havlir D, Feeney ME, Dorsey G, Gaw SL. Malar J. 2020 Jun 24;19(1):227. doi: 10.1186/s12936-020-03297-3. PMID: 32580739; PMCID: PMC7315526.
  8. Malaria in Pregnancy: What the Obstetric Provider in Nonendemic Areas Needs to Know.
    Zakama AK, Gaw SL. Obstet Gynecol Surv. 2019 Sep;74(9):546-556. doi: 10.1097/OGX.0000000000000704. Review. PMID: 31830300; PMCID: PMC7560991.
Coronavirus-19 (COVID-19) Infection and Vaccination in Pregnancy - Translational
  1. Pregnancy and lactation induce distinct immune responses to COVID-19 booster vaccination and SARS-CoV-2 breakthrough infection.
    Yin K†, Li L†, Luo X, Neidleman J, Cassidy AG, Golan Y, Ozarslan N, Lin CY, Jigmeddagva U, Ilala M, Chidboy MA, Prahl M*, Gaw SL*, Roan NR*. JCI Insight. 2025 Jul 22;10(14):e191930. doi: 10.1172/jci.insight.191930. PMID: 40693463. †Co-first authors. *Co-corresponding authors.
  2. Gestational SARS-CoV-2 Infection in a Ugandan Birth Cohort: High Incidence, Mild Maternal Disease, and Evidence of Association with Transient Infant Stunting
    Jacobson KB, Röltgen K, Lam B, Nayebare P, Kakuru A, Kizza J, Aguti M, Nankya F, Briggs J, Takahashi S, Greenhouse B, Rodriguez-Barraquer I, van der Ploeg K, Wohlstadter JN, Sigal GB, Roh ME, Nankabirwa JI, Cuu G, Gaw SL, Rosenthal PJ, Kamya MR, Ssewanyana I, Dorsey G, Boyd SD, Jagannathan P. Am J Trop Med Hyg. 2024 Sep 17:tpmd230801. doi: 10.4269/ajtmh.23-0801. Epub ahead of print. PMID: 39288758.
  3. Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy.
    Li L, Matsui Y, Prahl MK, Cassidy AG, Golan Y, Jigmeddagva U, Ozarslan N, Lin CY, Buarpung S, Gonzalez VJ, Chidboy MA, Basilio E, Lynch KL, Song D, Jegatheesan P, Rai DS, Govindaswami B, Needens J, Rincon M, Myatt L, Taha TY, Montano M, Ott M, Greene WC, Gaw SL. NPJ Vaccines. 2024 Aug 27;9(1):156. doi: 10.1038/s41541-024-00948-3. PMID: 39191763; PMCID: PMC11349990.
  4. Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants.
    Gonzalez VJ†, Li L†, Buarpung S, Prahl M, Robinson JF*, Gaw SL*. iScience. 2023 Aug 7;26(9):107549. doi: 10.1016/j.isci.2023.107549. PMID: 37664582; PMCID: PMC10470080. †Co-first authors; *Co-corresponding authors
  5. Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in Pregnancy.
    Cassidy AG, Li L, Golan Y, Gay C, Lin CY, Jigmeddagva U, Chidboy MA, Ilala M, Buarpung S, Gonzalez VJ, Basilio E, Duck M, Murtha AP, Wu AHB, Lynch KL, Asiodu IV, Prahl MK, Gaw SL. JAMA Netw Open. 2023 Jul 3;6(7):e2323405. doi: 10.1001/jamanetworkopen.2023.23405. PMID: 37450302; PMCID: PMC10349345.
  6. Analysis of placental pathology after COVID-19 by timing and severity of infection. 
    Corbetta-Rastelli CM, Altendahl M, Gasper C, Goldstein J, Afshar Y, Gaw SL. Am J Obstet Gynecol MFM. 2023 Jul;5(7):100981. doi: 10.1016/j.ajogmf.2023.100981. Epub 2023 Apr 23. PMID: 37094637; PMCID: PMC10122562.
  7. Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy. 
    Prahl M, Golan Y, Cassidy AG, Matsui Y, Li L, Alvarenga B, Chen H, Jigmeddagva U, Lin CY, Gonzalez VJ, Chidboy MA, Warrier L, Buarpung S, Murtha AP, Flaherman VJ, Greene WC, Wu AHB, Lynch KL, Rajan J, Gaw SL. Nat Commun. 2022 Jul 30;13(1):4422. doi: 10.1038/s41467-022-32188-1. PMID: 35908075; PMCID: PMC9338928.
  8. Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.
    Matsui Y†, Li L†, Prahl M, Cassidy AG, Ozarslan N, Golan Y, Gonzalez VJ, Lin CY, Jigmeddagva U, Chidboy MA, Montano M, Taha TY, Khalid MM, Sreekumar B, Hayashi JM, Chen PY, Kumar GR, Warrier L, Wu AH, Song D, Jegatheesan P, Rai DS, Govindaswami B, Needens J, Rincon M, Myatt L, Asiodu IV, Flaherman VJ, Afshar Y, Jacoby VL, Murtha AP, Robinson JF, Ott M, Greene WC*, Gaw SL*. JCI Insight. 2022 Jun 22;7(12):e157354. doi: 10.1172/jci.insight.157354. PMID: 35579965. †Co-first authors; *Co-corresponding authors
  9. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.  
    Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Chakraborty S, Dubey M, Ashraf U, Cheng BY, Kathale N, Tran KQT, Scallan C, Sinnott A, Cassidy A, Chen ST, Gelbart T, Gao F, Golan Y, Ji X, Kim-Schulze S, Prahl M, Gaw SL, Gnjatic S, Marron TU, Merad M, Arunachalam PS, Boyd SD, Davis MM, Holubar M, Khosla C, Maecker HT, Maldonado Y, Mellins ED, Nadeau KC, Pulendran B, Singh U, Subramanian A, Utz PJ, Sherwood R, Zhang S, Jagannathan P, Tan GS, Wang TT. Sci Transl Med. 2022 Mar 9;14(635):eabm7853. doi: 10.1126/scitranslmed.abm7853. Epub 2022 Mar 9. PMID: 35040666; PMCID: PMC8939764.
  10. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. 
    Sievers BL, Chakraborty S, Xue Y, Gelbart T, Gonzalez JC, Cassidy AG, Golan Y, Prahl M, Gaw SL, Arunachalam PS, Blish CA, Boyd SD, Davis MM, Jagannathan P, Nadeau KC, Pulendran B, Singh U, Scheuermann RH, Frieman MB, Vashee S, Wang TT, Tan GS. Sci Transl Med. 2022 Mar 2;14(634):eabn7842. doi: 10.1126/scitranslmed.abn7842. Epub 2022 Mar 2. PMID: 35025672; PMCID: PMC8891085.
  11. A standardized definition of placental infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) SARS-CoV-2 placental infection workshop. 
    Roberts DJ, Edlow AG, Romero RJ, Coyne CB, Ting DT, Hornick JL, Zaki SR, Adhikari UD, Serghides L, Gaw SL, Metz TD; all members of the NIH/NICHD SARS-CoV-2 Placental Infection Workshop. Am J Obstet Gynecol. 2021 Dec;225(6):593.e1-593.e9. doi: 10.1016/j.ajog.2021.07.029. Epub 2021 Aug 5. PMID: 34364845; PMCID: PMC8340595.
  12. Divergent early antibody responses define COVID-19 disease trajectories. 
    Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Dubey M, Cheng BY, Thi Tran KQ, Chakraborty S, Cassidy A, Chen ST, Sinnott A, Gelbart T, Golan Y, Prahl M, Singh U, Kim-Schulze S, Sherwood R, Zhang S, Marron TU, Gnjatic S, Gaw SL, Nadeau KC, Merad M, Jagannathan P, Tan GS, Wang TT.bioRxiv. 2021 May 25;. doi: 10.1101/2021.05.25.445649. PMID: 34075376;  PMCID: PMC8168384.
  13. Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: Prospective cohort study. 
    Song D, Prahl M, Gaw SL, Narasimhan SR, Rai DS, Huang A, Flores CV, Lin CY, Jigmeddagva U, Wu A, Warrier L, Levan J, Nguyen CBT, Callaway P, Farrington L, Acevedo GR, Gonzalez VJ, Vaaben A, Nguyen P, Atmosfera E, Marleau C, Anderson C, Misra S, Stemmle M, Cortes M, McAuley J, Metz N, Patel R, Nudelman M, Abraham S, Byrne J, Jegatheesan P.  BMJ Open. 2021 Jul 7;11(7):e053036. doi: 10.1136/bmjopen-2021-053036. PMID: 34234001; PMCID: PMC8264915.
Coronavirus-19 (COVID-19) Infection and Vaccination in Pregnancy- Clinical Epidemiology
  1. In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 Months.
    Jaswa EG, Huddleston HG, Lindquist KJ, Wu AHB, Bishop SL, Kim YS, Kaing A, Prahl M, Gaw SL, Corley J, Hoskin E, Cho YJ, Rogers EE, Cedars MI. In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 Months. JAMA Netw Open. 2024 Oct 1;7(10):e2439792. doi: 10.1001/jamanetworkopen.2024.39792. PMID: 39412802.
  2. Gestational SARS-CoV-2 Infection in a Ugandan Birth Cohort: High Incidence, Mild Maternal Disease, and Evidence of Association with Transient Infant Stunting
    Jacobson KB, Röltgen K, Lam B, Nayebare P, Kakuru A, Kizza J, Aguti M, Nankya F, Briggs J, Takahashi S, Greenhouse B, Rodriguez-Barraquer I, van der Ploeg K, Wohlstadter JN, Sigal GB, Roh ME, Nankabirwa JI, Cuu G, Gaw SL, Rosenthal PJ, Kamya MR, Ssewanyana I, Dorsey G, Boyd SD, Jagannathan P. Am J Trop Med Hyg. 2024 Sep 17:tpmd230801. doi: 10.4269/ajtmh.23-0801. Epub ahead of print. PMID: 39288758.
  3. Patterns of peripartum depression and anxiety during the pre-vaccine COVID-19 pandemic.
    Altendahl MR, Xu L, Asiodu I, Boscardin WJ, Gaw SL, Flaherman VJ, Jacoby VL, Richards MC, Krakow D, Afshar Y. BMC Pregnancy Childbirth. 2024 Apr 25;24(1):310. doi: 10.1186/s12884-024-06518-8. PMID: 38664729; PMCID: PMC11044399.
  4. In Utero Exposure to Maternal COVID-19 Vaccination and Offspring Neurodevelopment at 12 and 18 Months. 
    Jaswa EG, Cedars MI, Lindquist KJ, Bishop SL, Kim YS, Kaing A, Prahl M, Gaw SL, Corley J, Hoskin E, Cho YJ, Rogers E, Huddleston HG. JAMA Pediatr. 2024 Mar 1;178(3):258-265. doi: 10.1001/jamapediatrics.2023.5743. PMID: 38252445; PMCID: PMC10804280.
  5. Nirmatrelvir-Ritonavir (Paxlovid) for Mild Coronavirus Disease 2019 (COVID-19) in Pregnancy and Lactation. 
    Lin CY, Cassidy AG, Li L, Prahl MK, Golan Y, Gaw SL. Obstet Gynecol. 2023 May 1;141(5):957-960. doi: 10.1097/AOG.0000000000005152. Epub 2023 Mar 15. PMID: 36928334; PMCID: PMC10147578.
  6. Risk of pregnancy loss before 20 weeks' gestation in study participants with COVID-19.  
    Jacoby VL, Murtha A, Afshar Y, Gaw SL, Asiodu I, Tolosa J, Norton ME, Boscardin WJ, Flaherman V. Am J Obstet Gynecol. 2021 Oct;225(4):456-457. doi: 10.1016/j.ajog.2021.06.080. Epub 2021 Jun 24. PMID: 34175267; PMCID: PMC8225313.
  7. Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People. 
    Afshar Y, Gaw SL, Flaherman VJ, Chambers BD, Krakow D, Berghella V, Shamshirsaz AA, Boatin AA, Aldrovandi G, Greiner A, Riley L, Boscardin WJ, Jamieson DJ, Jacoby VL.  Obstet Gynecol. 2020 Dec;136(6):1117-1125. doi: 10.1097/AOG.0000000000004178. PMID: 33027186; PMCID: PMC7673633.
  8. Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study. 
    Flaherman VJ, Afshar Y, Boscardin J, Keller RL, Mardy A, Prahl MK, Phillips C, Asiodu IV, Berghella WV, Chambers BD, Crear-Perry J, Jamieson DJ, Jacoby VL, Gaw SL.  Clin Infect Dis. 2021 Nov 2;73(9):e2810-e2813. doi: 10.1093/cid/ciaa1411. PMID: 32947612; PMCID: PMC7543372.
  9. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19). 
    Blauvelt CA, Chiu C, Donovan AL, Prahl M, Shimotake TK, George RB, Schwartz BS, Farooqi NA, Ali SS, Cassidy A, Gonzalez JM, Gaw SL. Obstet Gynecol. 2020 Jul;136(1):46-51. doi: 10.1097/AOG.0000000000003949. PMID: 32384385
Lactational Immunology and Human Milk
  1. Genomic characterization of normal and aberrant human milk production. 
    Golan Y, Nyquist SK, Liu Z, Ennis D, Zhao J, Blair E, Khan AR, Prahl M, Gaw SL, Yassour M, Engelhardt BE, Flaherman VJ, Ahituv N.  Sci Adv. 2025 Sep 12;11(37):eadr7174. doi: 10.1126/sciadv.adr7174. Epub 2025 Sep 10. PMID: 40929253; PMCID: PMC12422191.
  2. Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection. 
    Golan Y, Ilala M, Li L, Gay C, Hunagund S, Lin CY, Cassidy AG, Jigmeddagva U, Matsui Y, Ozarslan N, Asiodu IV, Ahituv N, Flaherman VJ, Gaw SL*, Prahl M*. iScience. 2023 Aug 29;26(10):107767. doi: 10.1016/j.isci.2023.107767. PMID: 37731614; PMCID: PMC10507209. *Co-corresponding authors
  3. Effects of Vaccination Against Influenza, Pertussis, and COVID-19 on Human Milk Antibodies: Current Evidence and Implications for Health Equity. 
    Hunagund S, Golan Y, Asiodu IV, Prahl M, Gaw SL. Front Immunol. 2022 Jul 12;13:910383. doi: 10.3389/fimmu.2022.910383. PMID: 35903100; PMCID: PMC9314549.
  4. Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies.
    Pace RM, Williams JE, Järvinen KM, Meehan CL, Martin MA, Ley SH, Barbosa-Leiker C, Andres A, Yeruva L, Belfort MB, Caffé B, Navarrete AD, Lackey KA, Pace CDW, Gogel AC, Fehrenkamp BD, Klein M, Young BE, Rosen-Carole C, Diaz N, Gaw SL, Flaherman V, McGuire MA, McGuire MK, Seppo AE. Front Immunol. 2021 Dec 23;12:801797. doi: 10.3389/fimmu.2021.801797. PMID: 35003130; PMCID: PMC8733294.
  5. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads. 
    Golan Y, Prahl M, Cassidy AG, Gay C, Wu AHB, Jigmeddagva U, Lin CY, Gonzalez VJ, Basilio E, Chidboy MA, Warrier L, Buarpung S, Li L, Murtha AP, Asiodu IV, Ahituv N, Flaherman VJ, Gaw SL.  Front Immunol. 2021 Nov 3;12:777103. doi: 10.3389/fimmu.2021.777103. PMID: 34804068; PMCID: PMC8595828.
  6. Evaluating COVID-19 Vaccine-Related Messenger RNA in Breast Milk-Reply. 
    Golan Y, Flaherman VJ, Gaw SL. JAMA Pediatr. 2022 Jan 1;176(1):100-101. doi: 10.1001/jamapediatrics.2021.4087. PMID: 34661610.
  7. Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk. 
    Golan Y, Prahl M, Cassidy A, Lin CY, Ahituv N, Flaherman VJ, Gaw SL. JAMA Pediatr. 2021 Oct 1;175(10):1069-1071. doi: 10.1001/jamapediatrics.2021.1929. PMID: 34228115; PMCID: PMC8261686.
Zika Virus
  1. Middle Cerebral Artery Dopplers and Abnormal Neonatal Outcomes among Pregnant Women with Zika Virus Infection. 
    Mok T, Pereira JP Jr, Sobhani NC, Cardozo RF, Valle HA, Dutra BRT, Gama HD, Moreira ME, Vasconcelos Z, Pone M, Gaw SL. Am J Perinatol. 2022 Apr;39(6):577-583. doi: 10.1055/s-0041-1740057. Epub 2021 Nov 28. PMID: 34839482.
  2. Zika virus vertical transmission in children with confirmed antenatal exposure. 
    Brasil P, Vasconcelos Z, Kerin T, Gabaglia CR, Ribeiro IP, Bonaldo MC, Damasceno L, Pone MV, Pone S, Zin A, Tsui I, Adachi K, Pereira JP Jr, Gaw SL, Carvalho L, Cunha DC, Guida L, Rocha M, Cherry JD, Wang L, Aliyari S, Cheng G, Foo SS, Chen W, Jung J, Brickley E, Moreira MEL, Nielsen-Saines K. Nat Commun. 2020 Jul 14;11(1):3510. doi: 10.1038/s41467-020-17331-0. PMID: 32665616; PMCID: PMC7360785.
  3. Discordant Zika virus findings in twin pregnancies complicated by antenatal Zika virus exposure: a prospective cohort. 
    Sobhani NC, Avvad-Portari E, Nascimento ACM, Machado HN, Lobato DSS, Pereira JP, Esquivel MS, Vasconcelos ZC, Zin AA, Tsui I, Adachi K, Brickley EB, Fisher SJ, Nielsen-Saines K, Brasil P, Moreira ME, Gaw SL. J Infect Dis. 2020 May 11;221(11):1838-1845. doi: 10.1093/infdis/jiz629. PMID: 31773163; PMCID: PMC7213575.
  4. Early Clinical Infancy Outcomes for Microcephaly and/or SGA Zika-exposed Infants. 
    Adachi K, Romero T, Nielsen-Saines K, Pone S, Aibe M, Barroso de Aguiar E, Sim M, Brasil P, Zin A, Tsui I, Gaw SL, Halai UA, Vasconcelos Z, Pereira JP, Salles TS, Barbosa CN, Portari E, Cherry JD, Pone M, Moreira ME. Clin Infect Dis. 2020 Jun 10;70(12):2663-2672. doi: 10.1093/cid/ciz704. PMID: 31346616; PMCID: PMC7286378.
  5. Overlapping Spectrum of Retinochoroidal Scarring in Congenital Zika Virus and Toxoplasmosis Infections. 
    Tsui I, Neves LM, Adachi K, Gaw SL, Pereira JP Jr, Brasil P, Nielsen-Saines K, Moreira MEL, Zin AA. Ophthalmic Surg Lasers Imaging Retina. 2019 Dec 1;50(12):779-784. doi: 10.3928/23258160-20191119-05. PMID: 31877223; PMCID: PMC7247911.
  6. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. 
    Nielsen-Saines K, Brasil P, Kerin T, Vasconcelos Z, Gabaglia CR, Damasceno L, Pone M, Abreu de Carvalho LM, Pone SM, Zin AA, Tsui I, Salles TRS, da Cunha DC, Costa RP, Malacarne J, Reis AB, Hasue RH, Aizawa CYP, Genovesi FF, Einspieler C, Marschik PB, Pereira JP, Gaw SL, Adachi K, Cherry JD, Xu Z, Cheng G, Moreira ME. Nat Med. 2019 Aug;25(8):1213-1217. doi: 10.1038/s41591-019-0496-1. Epub 2019 Jul 8. PMID: 31285631; PMCID: PMC6689256.
  7. The Role of Amniocentesis in the Diagnosis of Congenital Zika Syndrome. 
    Pereira JP, Maykin MM, Vasconcelos Z, Avvad-Portari E, Zin AA, Tsui I, Brasil P, Nielsen-Saines K, Moreira ME, Gaw SL. Clin Infect Dis. 2019 Aug 1;69(4):713-716. doi: 10.1093/cid/ciz013. PMID: 30624579; PMCID: PMC6669287.
  8. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. 
    Nielsen-Saines K, Brasil P, Kerin T, Vasconcelos Z, Gabaglia CR, Damasceno L, Pone M, Abreu de Carvalho LM, Pone SM, Zin AA, Tsui I, Salles TRS, da Cunha DC, Costa RP, Malacarne J, Reis AB, Hasue RH, Aizawa CYP, Genovesi FF, Einspieler C, Marschik PB, Pereira JP, Gaw SL, Adachi K, Cherry JD, Xu Z, Cheng G, Moreira ME. Nat Med. 2019 Aug;25(8):1213-1217. doi: 10.1038/s41591-019-0496-1. Epub 2019 Jul 8. PMID: 31285631; PMCID: PMC6689256.
  9. Association Between Neonatal Neuroimaging and Clinical Outcomes in Zika-Exposed Infants From Rio de Janeiro, Brazil.  
    Pool KL, Adachi K, Karnezis S, Salamon N, Romero T, Nielsen-Saines K, Pone S, Boechat M, Aibe M, Gomes da Silva T, Ribeiro CTM, Boechat MI, Brasil P, Zin A, Tsui I, Gaw SL, Daltro P, Ribeiro BG, Fazecas T, Hygino da Cruz LC, Nogueira R, Vasconcelos Z, Pereira JP Jr, Saad Salles T, Barbosa CN, Chen W, Foo SS, Jung J, Moreira ME, Pone M.  JAMA Netw Open. 2019 Jul 3;2(7):e198124. doi: 10.1001/jamanetworkopen.2019.8124. PMID: 31365112; PMCID: PMC6669783.
  10. Neurodevelopment in Infants Exposed to Zika Virus In Utero. 
    Lopes Moreira ME, Nielsen-Saines K, Brasil P, Kerin T, Damasceno L, Pone M, Carvalho LMA, Pone SM, Vasconcelos Z, Ribeiro IP, Zin AA, Tsui I, Adachi K, Gaw SL, Halai UA, Salles TS, da Cunha DC, Bonaldo MC, Raja Gabaglia C, Guida L, Malacarne J, Costa RP, Gomes SC Jr, Reis AB, Soares FVM, Hasue RH, Aizawa CYP, Genovesi FF, Aibe M, Einspieler C, Marschik PB, Pereira JP Jr, Portari EA, Janzen C, Cherry JD. N Engl J Med. 2018 Dec 13;379(24):2377-2379. doi: 10.1056/NEJMc1800098. PMID: 30575464; PMCID: PMC6478167.
  11. Association of Prenatal Ultrasonographic Findings With Adverse Neonatal Outcomes Among Pregnant Women With Zika Virus Infection in Brazil. 
    Pereira JP Jr, Nielsen-Saines K, Sperling J, Maykin MM, Damasceno L, Cardozo RF, Valle HA, Dutra BRT, Gama HD, Adachi K, Zin AA, Tsui I, Vasconcelos Z, Brasil P, Moreira ME, Gaw SL. JAMA Netw Open. 2018 Dec 7;1(8):e186529. doi: 10.1001/jamanetworkopen.2018.6529.  PMID: 30646333; PMCID: PMC6324324.
  12. Visual function in infants with antenatal Zika virus exposure. 
    Zin AA, Tsui I, Rossetto JD, Gaw SL, Neves LM, Zin OA, Haefeli L, Barros Silveira Filho JC, Adachi K, Vinicius da Silva Pone M, Pone SM, Molleri N, Pereira JP Jr, Belfort R, Arumugaswami V, Vasconcelos Z, Brasil P, Nielsen-Saines K, Lopes Moreira ME. J AAPOS. 2018 Dec;22(6):452-456.e1. doi: 10.1016/j.jaapos.2018.07.352. Epub 2018 Oct 22. PMID: 30359768;  PMCID: PMC6289819.
  13. Eye Findings in Infants With Suspected or Confirmed Antenatal Zika Virus Exposure. 
    Tsui I, Moreira MEL, Rossetto JD, Vasconcelos Z, Gaw SL, Neves LM, Zin OA, Haefeli L, Silveira Filho JCB, Gomes SC Jr, Adachi K, Pone MVDS, Pone SM, Pereira JP Jr, Belfort R, Arumugaswami V, Brasil P, Nielsen-Saines K, Zin AA. Pediatrics. 2018 Oct;142(4). doi: 10.1542/peds.2018-1104. Epub 2018 Sep 13.  PMID: 30213843; PMCID: PMC6317824.
  14. Gottesfeld-Hohler Memorial Foundation Zika Virus Think Tank Summary. 
    Hobbins JC, Platt LD, Copel JA, Euser AG, Afshar Y, Irani RA, Levine D, Sanz Cortes M, Abuhamad A, Gaw SL, Harris K, Herrera M, Lynch L, Melo A, Noguchi L, Aguiar R, Sheffield JS, Minton KK. Obstet Gynecol. 2018 Apr;131(4):661-665. doi: 10.1097/AOG.0000000000002538. PMID: 29528928.
  15. Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017. 
    Adebanjo T, Godfred-Cato S, Viens L, Fischer M, Staples JE, Kuhnert-Tallman W, Walke H, Oduyebo T, Polen K, Peacock G, Meaney-Delman D, Honein MA, Rasmussen SA, Moore CA; Contributors. MMWR Morb Mortal Wkly Rep. 2017 Oct 20;66(41):1089-1099. PMID: 29049277; PMCID: PMC5689094.
  16. Maternal Zika Virus Disease Severity, Virus Load, Prior Dengue Antibodies, and Their Relationship to Birth Outcomes. 
    Halai UA, Nielsen-Saines K, Moreira ML, de Sequeira PC, Junior JPP, de Araujo Zin A, Cherry J, Gabaglia CR, Gaw SL, Adachi K, Tsui I, Pilotto JH, Nogueira RR, de Filippis AMB, Brasil P. Clin Infect Dis. 2017 Sep 15;65(6):877-883. doi: 10.1093/cid/cix472. PMID: 28535184; PMCID: PMC5848222.
  17. Screening Criteria for Ophthalmic Manifestations of Congenital Zika Virus Infection. 
    Zin AA, Tsui I, Rossetto J, Vasconcelos Z, Adachi K, Valderramos S, Halai UA, Pone MVDS, Pone SM, Silveira Filho JCB, Aibe MS, da Costa ACC, Zin OA, Belfort R Jr, Brasil P, Nielsen-Saines K, Moreira MEL. JAMA Pediatr. 2017 Sep 1;171(9):847-854. doi: 10.1001/jamapediatrics.2017.1474. PMID: 28715527; PMCID: PMC5710409.
  18. Zika Risk and Pregnancy in Clinical Practice: Ongoing Experience as the Outbreak Evolves. 
    Rao R, Gaw SL, Han CS, Platt LD, Silverman NS.Obstet Gynecol. 2017 Jun;129(6):1098-1103. doi: 10.1097/AOG.0000000000002049.  PMID: 28486369.
  19. Zika Virus Infection in Pregnant Women in Rio de Janeiro. 
    Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, Zin AA, Horovitz D, Daltro P, Boechat M, Raja Gabaglia C, Carvalho de Sequeira P, Pilotto JH, Medialdea-Carrera R, Cotrim da Cunha D, Abreu de Carvalho LM, Pone M, Machado Siqueira A, Calvet GA, Rodrigues Baião AE, Neves ES, Nassar de Carvalho PR, Hasue RH, Marschik PB, Einspieler C, Janzen C, Cherry JD, Bispo de Filippis AM, Nielsen-Saines K. N Engl J Med. 2016 Dec 15;375(24):2321-2334. doi: 10.1056/NEJMoa1602412. Epub 2016 Mar 4. PMID: 26943629; PMCID: PMC5323261.
  20. From Mosquitos to Humans: Genetic Evolution of Zika Virus.  
    Wang L*, Valderramos SG*, Wu A, Ouyang S, Li C, Brasil P, Bonaldo M, Coates T, Nielsen-Saines K, Jiang T, Aliyari R, Cheng G.  Cell Host Microbe. 2016 May 11;19(5):561-5. doi: 10.1016/j.chom.2016.04.006. Epub 2016 Apr 15. PMID: 27091703; PMCID: PMC5648540. (*Co-first author) 
Immunology of Pregnancy
  1. Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm Birth.
    Rackaityte E, Borges B, Kortbawi HM, Miller HS, Shao SJ, Zorn KC, Caspar C, Wong R, McCarthy F, Creery JS, Mayer M, Kouame E, Puccinelli RR, Kistler AL, Yu DJL, Ganem SR, DeRisi A, Kawaja Q, Wang CY, Saxena A, Oltman S, Kung AF, Mann SA, Mitchell A, Huang D, Rizzuto G, Baer RJ, Mandel-Brehm C, Ryckman KK, Gaw SL, Hillman SL, Jelliffe-Pawlowski LL, Halkias J, Sobhani NC, Anderson MS, Trespidi F, Alpin C, Bosoni T, Albertini R, Bellingeri C, Gardella B, Borghesi A, Prince N, Lasky-Su J, Wilson MR, Cedars M, Elias JE, MacKenzie TC, DeRisi JL.  medRxiv [Preprint]. 2025 Dec 5:2024.10.03.24314850. doi: 10.1101/2024.10.03.24314850. PMID: 41568202; PMCID: PMC12817887.
  2. Regulatory KIR+CD8+ T cells are elevated during human pregnancy.
    Li J, Wang X, Lackner AI, Narasimhan P, Li L, Mallajosyula V, Johnson MM, Höbler AL, Kirosingh AS, Braun AE, Nankya F, Musinguzi K, Kakuru A, Kamya M, Rosenthal PJ, Dorsey G, Jagannathan P, Angelo M, Pollheimer J, Gaw SL, Winn VD, Nadeau KC, Davis MM.  Sci Transl Med. 2025 Aug 6;17(810):eadm7697. doi: 10.1126/scitranslmed.adm7697. Epub 2025 Aug 6. PMID: 40768597.
  3. Gravidity influences distinct transcriptional profiles of maternal and fetal placental macrophages at term.
    Ozarslan N, Robinson JF, Buarpung S, Kim MY, Ansbro MR, Akram J, Montoya DJ, Kamya MR, Kakuru A, Dorsey G, Rosenthal PJ, Cheng G, Feeney ME, Fisher SJ, Gaw SL.  Front Immunol. 2024;15:1384361. doi: 10.3389/fimmu.2024.1384361. eCollection 2024. PubMed PMID: 38994356; PubMed Central PMCID: PMC11237841.
Vaccine Uptake and Acceptance in Pregnancy and Lactation
  1. Regional variation in maternal RSV vaccine access and attitudes across two California cohorts.
    Cirillo AA, Zeme M, Morales A, Rahseparian N, Cortez C, Gaw SL, Blauvelt CA.  Prev Med Rep. 2026 Feb 11;63:103408. doi: 10.1016/j.pmedr.2026.103408. PMID: 41756026; PMCID: PMC12933853.
  2. Respiratory Syncytial Virus Vaccination Acceptance: The Importance of Asking "Why?".
    Zeme M, Gaw SL. J Pediatr Clin Pract. 2025 Jul 7;17:200163. doi: 10.1016/j.jpedcp.2025.200163. PMID: 40703621; PMCID: PMC12284778.
  3. Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates. 
    Blauvelt CA, Zeme M, Natarajan A, Epstein A, Roh ME, Morales A, Bourdoud N, Flaherman VJ, Prahl MK, Gaw SL. JAMA Netw Open. 2025 Feb 3;8(2):e2460735. doi: 10.1001/jamanetworkopen.2024.60735.  PMID: 39969879; PMCID: PMC11840647.
  4. Disparities in COVID-19 Vaccine Uptake Among Pregnant People in a Diverse Urban Population With High Vaccine Acceptance. 
    Blauvelt CA, Pullins MJ, Gaw SL. AJPM Focus. 2025 Jun;4(3):100303. doi: 10.1016/j.focus.2024.100303. eCollection 2025 Jun. PMID: 39967683; PMCID: PMC11834080.
  5. Provider Guidance for the Prevention of Respiratory Syncytial Virus in Infants: Maternal Vaccination Versus Infant Monoclonal Antibody Treatment.
    Cirillo AA, Gaw SL. Obstet Gynecol Surv. 2024 Oct;79(10):585-590. doi: 10.1097/OGX.0000000000001324. PMID: 39437376.
  6. COVID-19 Vaccination Patterns and Attitudes Among American Pregnant Individuals.  
    Huddleston HG, Jaswa EG, Lindquist KJ, Kaing A, Morris JR, Hariton E, Corley J, Hoskin E, Gaw SL, Cedars MI. Am J Obstet Gynecol MFM. 2022 Jan;4(1):100507. doi: 10.1016/j.ajogmf.2021.100507. Epub 2021 Oct 11. PMID: 34649015; PMCID: PMC8502724.
Sepsis and Febrile Illness in Pregnancy
  1. Maternal fever during labor and the risk of neonatal encephalopathy: duration and magnitude of hyperthermia.
    Cornet MC, Kuzniewicz MW, Scheffler AW, Garabedian C, Gaw SL, Wu YW.  Am J Obstet Gynecol. 2025 Aug 5;. doi: 10.1016/j.ajog.2025.07.046. [Epub ahead of print] PubMed PMID: 40754173; PubMed Central PMCID: PMC12412422.
  2. Epidural Analgesia During Labor and Neonatal Hypoxic-Ischemic Encephalopathy
    Cornet MC, Kuzniewicz MW, Scheffler AW, Gaw SL, Yeh P, Newman TB, Wu YW. JAMA Netw Open. 2024 Sep 3;7(9):e2433730. doi: 10.1001/jamanetworkopen.2024.33730. PMID: 39283635; PMCID: PMC11406397.
  3. Monthly Sulfadoxine-Pyrimethamine During Pregnancy Prevents Febrile Respiratory Illnesses: A Secondary Analysis of a Malaria Chemoprevention Trial in Uganda. 
    Lee JJ, Kakuru A, Jacobson KB, Kamya MR, Kajubi R, Ranjit A, Gaw SL, Parsonnet J, Benjamin-Chung J, Dorsey G, Jagannathan P, Roh ME.  Open Forum Infect Dis. 2024 Apr;11(4):ofae143. doi: 10.1093/ofid/ofae143. eCollection 2024 Apr. PMID: 38585183; PMCID: PMC10995957.
  4. Predictors of antepartum maternal sepsis and effects on neonatal outcomes: a population-based cohort study.
    Ozarslan N, Gaw SL, Cassidy AG, Caughey AB. J Perinatol. 2023 Jun;43(6):752-757. doi: 10.1038/s41372-023-01696-3. Epub 2023 May 22. PMID: 37217673..
  5. Perinatal Outcomes Among Patients With Sepsis During Pregnancy.
    Blauvelt CA, Nguyen KC, Cassidy AG, Gaw SL. JAMA Netw Open. 2021 Sep 1;4(9):e2124109. doi: 10.1001/jamanetworkopen.2021.24109. PMID: 34477848.
Wildfire Exposure in Pregnancy
  1. Retrospective analysis of wildfire smoke exposure and birth weight outcomes in the San Francisco Bay Area of California. 
    Fernández ACG, Basilio E, Benmarhnia T, Roger J, Gaw SL, Robinson JF, Padula AM.Environ Res Health. 2023 Jun 1;1(2):025009. doi: 10.1088/2752-5309/acd5f5. Epub 2023 Jun 13. PMID: 37324234; PMCID: PMC10261910.
  2. Gestational age-dependent decrease in fetal Hofbauer cells in placentas from pregnancies exposed to wildfire smoke in California. 
    Basilio E, Ozarslan N, Buarpung S, Benmarhnia T, Padula AM, Robinson JF, Gaw SL.  medRxiv. 2023 Jan 12;. doi: 10.1101/2023.01.11.23284125. PMID: 36712106; PMCID: PMC9882560.
  3. Wildfire Smoke Exposure during Pregnancy: A Review of Potential Mechanisms of Placental Toxicity, Impact on Obstetric Outcomes, and Strategies to Reduce Exposure. 
    Basilio E, Chen R, Fernandez AC, Padula AM, Robinson JF, Gaw SL. Int J Environ Res Public Health. 2022 Oct 22;19(21). doi: 10.3390/ijerph192113727. Review. PMID: 36360613; PMCID: PMC9657128.
Biomarkers of Pregnancy Complications
  1. Stressful life events and hypertensive disorders of pregnancy: The role of maternal and fetal inflammation.
    Eick SM, Ortlund K, Dunlop AL, Li L, Morello-Frosch R, Woodruff TJ, Gaw SL, Brennan PA, Liang D, Barr DB, Robinson JF, Goin DE.  Pregnancy Hypertens. 2026 Mar 12;44:101440. doi: 10.1016/j.preghy.2026.101440. Epub ahead of print. PMID: 41825090.
  2. Serum soluble fms-like tyrosine kinase kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy.
    Berg AH, Calsavara VF, Hund M, Guo G, Rana S, Costantine MM, Espinoza J, Boggess K, Wylie BJ, Moore Simas TA, Louis JM, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Bautista M, Lemoine E, Kilpatrick S, Thadhani R, Karumanchi SA.  Am J Obstet Gynecol. 2025 Nov 11:S0002-9378(25)00828-2. doi: 10.1016/j.ajog.2025.11.006. Epub ahead of print. PMID: 41232788.
  3. Psychosocial stress and associations with inflammation in mid-gestation maternal, fetal, and placental tissue.
    Sehgal N, Li L, Goin DE, Chen J, Jigmeddagva U, Morello-Frosch R, Woodruff TJ, Gaw SL, Robinson JF, Eick SM. Reprod Toxicol. 2025 Apr 18;135:108922. doi: 10.1016/j.reprotox.2025.108922. Epub ahead of print. PMID: 40254104.
  4. Plasma sFlt-1/PlGF ratio of 11.5 multiples of median predicts preeclampsia with severe features within two weeks of testing. 
    Espinoza J, Calsavara VF, Kilpatrick S, Rana S, Costantine MM, Boggess K, Wylie BJ, Moore Simas TA, Louis JM, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Lemoine E, Thadhani R, Karumanchi SA.  Am J Obstet Gynecol. 2024 May 31;. doi: 10.1016/j.ajog.2024.05.050. [Epub ahead of print] PMID: 38825028.
  5. Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy.
    Thadhani R, Lemoine E, Rana S, Costantine MM, Calsavara VF, Boggess K, Wylie BJ, Simas TAM, Louis JM, Espinoza J, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Gaden A, Bautista M, Chang Y, Diniz MA, Karumanchi SA, Kilpatrick S.  NEJM Evidence. 2022;1(12):EVIDoa2200161. 2022; 12(1). DOI:https://doi.org/10.1056/EVIDoa2200161.
  6. Integrated analysis of transcriptomic datasets to identify placental biomarkers of spontaneous preterm birth. 
    Sobhani NC, Mernoff R, Abraha M, Okorie CN, Marquez-Magana L, Gaw SL, Robinson JF.  Placenta. 2022 May;122:66-73. doi: 10.1016/j.placenta.2022.03.122. Epub 2022 Apr 4. PMID: 35462239; PMCID: PMC9715015.
Clinical Obstetrics
  1. Validated Calculators Predicting Cesarean Delivery After Induction: Accuracy in an External Population. 
    Shao SJ, Teal EN, Lewkowitz AK, Gaw SL, Sobhani NC. Obstet Gynecol. 2023 Jul 1;142(1):99-107. doi: 10.1097/AOG.0000000000005234. Epub 2023 Jun 7. PMID: 37290103.
  2. Relationship between maternal age and labor induction duration and outcomes in nulliparous women.
    Teal EN, Gaw SL, Has P, Lewkowitz AK. J Matern Fetal Neonatal Med. 2022 Dec;35(25):6973-6980. doi: 10.1080/14767058.2021.1932807. Epub 2021 Jun 8. PMID: 34102937.
  3. Impact of Therapeutic Rest in Early Labor on Perinatal Outcomes: A Prospective Study. 
    Maykin MM, Ukoha EP, Tilp V, Gaw SL, Lewkowitz AK. Am J Obstet Gynecol MFM. 2021 May;3(3):100325. doi: 10.1016/j.ajogmf.2021.100325. Epub 2021 Feb 2. PMID: 33545440.
  4. Revisiting the Role of Health Care Proxies in Reproductive Choice. 
    Narayana S, Gaw SL, Aldrich JM, Guterman EL. Obstet Gynecol. 2021 Jan 1;137(1):170-172. doi: 10.1097/AOG.0000000000004196. PMID: 33278283.
  5. Quantifying the Risks and Benefits of Continuing Labor Induction: Data for Shared Decision-Making. 
    Teal EN, Lewkowitz AK, Koser SLP, Tran CBN, Gaw SL. Am J Perinatol. 2021 Jul;38(9):935-943. doi: 10.1055/s-0039-1701025. Epub 2020 Feb 3. PMID: 32016925.
  6. Identifying risk factors for perinatal death at Tororo District Hospital, Uganda: a case-control study. 
    Tesfalul MA, Natureeba P, Day N, Thomas O, Gaw SL. BMC Pregnancy Childbirth. 2020 Jan 20;20(1):45. doi: 10.1186/s12884-020-2727-3. PMID: 31959141; PMCID: PMC6972019.
  7. Vaginal birth after cesarean: Does accuracy of predicted success change from prenatal intake to admission? 
    Ha TK, Rao RR, Maykin MM, Mei JY, Havard AL, Gaw SL.  Am J Obstet Gynecol MFM. 2020 May;2(2):100094. doi: 10.1016/j.ajogmf.2020.100094. Epub 2020 Mar 7. PMID: 33345960.
  8. Impact of Gestational Weight Gain on Trial of Labor after Cesarean Success. 
    Mei JY, Havard AL, Mularz AJ, Maykin MM, Gaw SL. Am J Perinatol. 2019 Aug;36(10):1023-1030. doi: 10.1055/s-0038-1675624. Epub 2018 Nov 30. PMID: 30500964.
  9. Impact of obesity class on trial of labor after cesarean success: does pre-pregnancy or at-delivery obesity status matter?. 
    Mei JY, Havard AL, Mularz AJ, Maykin MM, Gaw SL. J Perinatol. 2019 Aug;39(8):1042-1049. doi: 10.1038/s41372-019-0386-x. Epub 2019 May 15. PMID: 31092887.
  10. The impact of cerclage in twin pregnancies on preterm birth rate before 32 weeks. 
    Han MN, O'Donnell BE, Maykin MM, Gonzalez JM, Tabsh K, Gaw SL. J Matern Fetal Neonatal Med. 2019 Jul;32(13):2143-2151. doi: 10.1080/14767058.2018.1427719. Epub 2018 Jan 23. PMID: 29363371; PMCID: PMC6251764.
  11. Validation of a Prediction Model for Vaginal Birth after Cesarean Delivery Reveals Unexpected Success in a Diverse American Population. 
    Maykin MM, Mularz AJ, Lee LK, Valderramos SG. AJP Rep. 2017 Jan; 7(1):e31-e38. PMID: 28255520; PMCID: PMC5330796.
  12. Power analysis for the MEXPRE study. 
    Nguyen TA, Mularz AJ, Valderramos SG. Am J Obstet Gynecol. 2014 Aug;211(2):182. doi: 10.1016/j.ajog.2014.03.002. Epub 2014 Mar 5. No abstract available. PMID: 24613221
 
Environmental Chemicals and Placental Development
  1. An ex vivo human placental explant model for controlled exposure studies. 
    Ozarslan N, Li L, Buarpung S, Robinson JF, Gaw SL. STAR Protoc. 2025 Sep 19;6(3):104055. doi: 10.1016/j.xpro.2025.104055. Epub 2025 Aug 29. PMID: 40886312; PMCID: PMC12418815.
  2. Associations between brominated and organophosphate flame retardant levels and inflammatory biomarkers in maternal blood, cord blood, and placental tissue at mid-gestation. 
    Nguyen V, Sehgal N, Li L, Goin DE, Morello-Frosch R, Woodruff TJ, Varshavsky J, Park JS, Gaw SL, Robinson JF, Eick SM.  Sci Total Environ. 2025 Sep 16;1001:180501. doi: 10.1016/j.scitotenv.2025.180501. Epub ahead of print. PMID: 40961615; PMCID: PMC12462692.
  3. Profiling the Cytotoxic Effects of Naled and Other Pesticides in Primary Human Placental Cytotrophoblast.
    Li L†, Chen H†, Jigmeddagva U, Le N, Kapidzic M, Gee S, Ali A, Levan J, Person R, Chen J, Gutierrez A, Okorie CN, Wang M, Woodruff TJ, Fisher SJ, Gaw SL, Robinson JF. Toxicol Sci. 2025 May 28:kfaf038. doi: 10.1093/toxsci/kfaf038. Epub ahead of print. PMID: 40434365. †Co-first authors
  4. Perfluorooctanoic Acid Induces Transcriptomic Alterations in 2nd Trimester Human Cytotrophoblasts. 
    Chen H, Kapidzic M, Gantar D, Aksel S, Levan J, Abrahamsson DP, Jigmeddagva U, Basrai S, San A, Gaw SL, Woodruff TJ, Fisher SJ, Robinson JF. Toxicol Sci. 2023 Nov 28;196(2):187-199. doi: 10.1093/toxsci/kfad097. PMID: 37738295; PMCID: PMC10682971.
  5. Organophosphate Flame Retardants, Highly Fluorinated Chemicals, and Biomarkers of Placental Development and Disease during Mid-Gestation. 
    Varshavsky JR, Robinson JF, Zhou Y, Puckett KA, Kwan E, Buarpung S, Aburajab R, Gaw SL, Sen S, Gao S, Smith SC, Park JS, Zakharevich I, Gerona RR, Fisher SJ, Woodruff TJ. Organophosphate Flame Retardants, Highly Fluorinated Chemicals, and Biomarkers of Placental Development and Disease During Mid-Gestation. Toxicol Sci. 2021 May 27;181(2):215-228. doi: 10.1093/toxsci/kfab028. PMID: 33677611; PMCID: PMC8163039.
  6. Association of polybrominated diphenyl ether (PBDE) levels with biomarkers of placental development and disease during mid-gestation. 
    Varshavsky JR, Robinson JF, Zhou Y, Puckett KA, Kwan E, Buarpung S, Aburajab R, Gaw SL, Sen S, Smith SC, Frankenfield J, Park JS, Fisher SJ, Woodruff TJ. Environ Health. 2020 Jun 3;19(1):61. doi: 10.1186/s12940-020-00617-7. PMID: 32493340; PMCID: PMC7268484.
Ophthalmologic Changes in Pregnancy
  1. Relative Postpartum Retinal Vasoconstriction Detected With Optical Coherence Tomography Angiography. 
    Lin BR, Lin F, Su L, Nassisi M, Sadda SR, Gaw SL, Tsui I. Transl Vis Sci Technol. 2021 Feb 5;10(2):40. doi: 10.1167/tvst.10.2.40. PMID: 34003925; PMCID: PMC7910633.
  2. Maternal Optical Coherence Tomography Angiography Changes Related to Small for Gestational Age Pregnancies. 
    Su L, Lin BR, Lin F, Tsui IK, Gaw SL, Janzen C, Sadda SR, Tsui I. . Transl Vis Sci Technol. 2020 Dec 3;9(13):4. doi: 10.1167/tvst.9.13.4. PMID: 33344048; PMCID: PMC7718826.
  3. Utility of optical coherence tomography angiography in pregnancy-associated central serous chorioretinopathy. 
    Pole C, Gaw SL, Tsui I. Am J Ophthalmol Case Rep. 2020 Dec;20:100979. doi: 10.1016/j.ajoc.2020.100979. eCollection 2020 Dec. PMID: 33145456; PMCID: PMC7595881.
  4. Evaluation of the Choroid in Women with Uncomplicated Pregnancy. 
    Su L, Taweebanjongsin W, Gaw SL, Rabina G, Sadda SR, Tsui I. Transl Vis Sci Technol. 2020 Aug;9(9):24. doi: 10.1167/tvst.9.9.24. eCollection 2020 Aug. PMID: 32879780; PMCID: PMC7442858.
  5. Retinal Vascular Changes During Pregnancy Detected With Optical Coherence Tomography Angiography. 
    Chanwimol K, Balasubramanian S, Nassisi M, Gaw SL, Janzen C, Sarraf D, Sadda SR, Tsui I. Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2726-2732. doi: 10.1167/iovs.19-26956. PMID: 31247113.
Prenatal Diagnosis
  1. Clinical accuracy of abnormal cell-free fetal DNA results for the sex chromosomes. 
    Scibetta EW, Gaw SL, Rao RR, Silverman NS, Han CS, Platt LD.  Prenat Diagn. 2017 Dec;37(13):1291-1297. doi: 10.1002/pd.5146. Epub 2017 Nov 26. PMID: 28837243.
  2. The value of the first trimester ultrasound in the era of cell free DNA screening. 
    Rao RR, Valderramos SG, Silverman NS, Han CS, Platt LD. Prenat Diagn. 2016 Dec;36(13):1192-1198. doi: 10.1002/pd.4955. Epub 2016 Dec 2. PMID: 27813114.
  3. Cell-free DNA screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results.  
    Valderramos SG, Rao RR, Scibetta EW, Silverman NS, Han CS, Platt LD. Am J Obstet Gynecol. 2016 Nov;215(5):626.e1-626.e10. doi: 10.1016/j.ajog.2016.06.039. Epub 2016 Jun 28. PMID: 27371353; PMCID: PMC5613931.
  4. Perinatal outcomes in euploid pregnancies with 'double-positive' first trimester prenatal screening for trisomy 18 and 21. 
    Yee LM, Valderramos SG, Pena S, Cheng YW, Bianco K. J Perinatol. 2013 Nov;33(11):836-40. doi: 10.1038/jp.2013.88. Epub 2013 Jul 25.  PMID: 23887195
 
Drug Resistance in Plasmodium falciparum Malaria
  1. Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT. 
    Lehane AM, van Schalkwyk DA, Valderramos SG, Fidock DA, Kirk K. Antimicrob Agents Chemother. 2011 May;55(5):2310-8. doi: 10.1128/AAC.01167-10. Epub 2011 Feb 22. PMID: 21343459.
  2. Investigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance. 
    Valderramos SG, Scanfeld D, Uhlemann AC, Fidock DA, Krishna S. Antimicrob Agents Chemother. 2010 Sep;54(9):3842-52. doi: 10.1128/AAC.00121-10. Epub 2010 Jun 21. PMID: 20566762
  3. Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. 
    Valderramos SG, Valderramos JC, Musset L, Purcell LA, Mercereau-Puijalon O, Legrand E, Fidock DA. PLoS Pathog. 2010 May 13;6(5):e1000887. doi: 10.1371/journal.ppat.1000887. PMID: 20485514
  4. Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites. 
    Hunt P, Afonso A, Creasey A, Culleton R, Sidhu AB, Logan J, Valderramos SG, McNae I, Cheesman S, do Rosario V, Carter R, Fidock DA, Cravo P. Mol Microbiol. 2007 Jul;65(1):27-40. PMID: 17581118
  5. X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy. 
    Freundlich JS, Wang F, Tsai HC, Kuo M, Shieh HM, Anderson JW, Nkrumah LJ, Valderramos JC, Yu M, Kumar TR, Valderramos SG, Jacobs WR Jr, Schiehser GA, Jacobus DP, Fidock DA, Sacchettini JC. J Biol Chem. 2007 Aug 31;282(35):25436-44. Epub 2007 Jun 13. PMID: 17567585
  6. Transporters involved in resistance to antimalarial drugs. 
    Valderramos SG, Fidock DA. Trends Pharmacol Sci. 2006 Nov;27(11):594-601. Epub 2006 Sep 25. Review. PMID: 16996622
  7. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. 
    Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA. J Infect Dis. 2006 Aug 15; 194(4):528-35. PMID: 16845638.
  8. First evidence of pfcrt mutant Plasmodium falciparum in Madagascar. 
    Randrianarivelojosia M, Fidock DA, Belmonte O, Valderramos SG, Mercereau-Puijalon O, Ariey F. Trans R Soc Trop Med Hyg. 2006 Sep; 100(9):826-30. PMID: 16442577.
  9. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. 
    Sidhu AB, Valderramos SG, Fidock DA. Mol Microbiol. 2005 Aug; 57(4):913-26. PMID: 16091034
 
MHC I Antigen Processing